glp-1 anesthesia guidelines How should we approach patients on agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like aGLP-1 receptor agonists & anesthesia:

394 :e100077 doi:10.1136/bmj-2026-100077 Dr Kartikeya Kohli, Senior Consultant in Internal Medicine and specialist in Diabetes,Obesity and kidney diseases has done his DNB (Medicine), MRCP (UK)

People who suffer from AFS sometimes experience hair loss and dry, thin skin

Individual variation is considerable , and some patients report resolution of fatigue within 2 to 3 weeks, whilst others may experience symptoms for a longer duration

Myrosinase is needed to convert sulforaphane glucosinolate into sulforaphane in the small intestine

In fact, GLP-1 prescription is said to lessen incidence and severity of these conditions and result in improved morbidity and mortality

Other ingredients: Cellulose,gelatin (capsule),silica and vegetable stearate